Corporate Counsel Weekly™ helps corporate lawyers get the big picture on the legal challenges facing corporations today. Practitioners can discover trends on the horizon and stay alert to the full...
By Mary Hughes
Oct. 8 — Equity compensation grants made by large U.S. companies in traditional and technology industries favored restricted stock awards in 2013, continuing a trend away from stock options, according to a study of publicly traded companies' stock compensation disclosures.
The “Stock Compensation 2014 Assumption and Disclosure Study,” released Oct. 7 by PricewaterhouseCoopers LLP, analyzed 2013 Form 10-K filings of companies with a Dec. 31 fiscal year-end and disclosing stock compensation expense. Companies included in the study are the top 100 companies in the Standard & Poor's 500 index and the top 100 technology companies on the Nasdaq technology, biotechnology and pharmaceutical industry lists.
The study found that, among the large companies, equity award grant types were split 51 percent restricted stock to 49 percent stock options. Among large technology companies, the split was even more pronounced, at 59 percent restricted stock and 41 percent stock options.
The value of restricted stock awards far exceeds the value of stock options granted in 2013 in both large companies and large technology companies, according to the study. In terms of value, among the large companies, in 2009 the ratio of stock to option awards was about 2.5-to-1, growing to almost 6-to-1 in 2013. On the technology side, the ratio grew from about 3-to-2 in 2009 to almost 6-to-1 in 2013, the study said.
To contact the reporter on this story: Mary Hughes in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Phil Kushin at email@example.com
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)